[1]
M. MATHEW, D. KILIMOZHI, S. M. MATHEWS, and A. SMITH, “DESIGN, SYNTHESIS, AND BIO PROFILING OF 2, 3-DIHYDROQUINAZOLIN-4(1H)-ONE DERIVATIVE AS TYPE II DIABETES AGENTS: A COMPREHENSIVE IN SILICO, IN VITRO, AND IN VIVO STUDY”, Int J App Pharm, vol. 16, no. 6, pp. 329–339, Nov. 2024.